Chen‐ye Shao, Kai‐chao Liu, and Chu‐ling Li contributed equally to this work and are co‐first authors.

Introduction {#tca12990-sec-0005}
============

The morbidity and mortality resulting from anastomotic leakage (AL) after esophagectomy have steadily decreased during the last several decades with improvements in surgical techniques and management during the perioperative period[1](#tca12990-bib-0001){ref-type="ref"} In spite of these advances, AL remains a significant cause of surgery‐related death and an impairment to quality of life[2](#tca12990-bib-0002){ref-type="ref"} AL prolongs hospital stay, increases expenses, and has been proven to be associated with postoperative tumor recurrence[3](#tca12990-bib-0003){ref-type="ref"} Without timely or correct treatment, AL can lead to severe chest or mediastinal infections, which can be life‐threatening[4](#tca12990-bib-0004){ref-type="ref"} Therefore, it is particularly important to construct methods that could help to identify high‐risk postoperative patients in order to administer timely treatment.

The process of AL development induces a strong systematic inflammatory response. Previous studies have shown that some circulating acute phase proteins (such as C‐reactive protein \[CRP\] and albumin) are associated with surgery‐related systematic inflammatory response[5](#tca12990-bib-0005){ref-type="ref"} Postoperative CRP has been assessed as a good indicator for the early detection of AL after colorectal surgery and esophagectomy and in rectal cancer and esophageal cancer in both neoadjuvant and non‐neoadjuvant patients[6](#tca12990-bib-0006){ref-type="ref"}, [7](#tca12990-bib-0007){ref-type="ref"}, [8](#tca12990-bib-0008){ref-type="ref"} Albumin is a sensitive response indicator to surgical stress; postoperative albumin has been evaluated as a potential predictor of clinical complications[9](#tca12990-bib-0009){ref-type="ref"} A novel indicator, the CRP to albumin ratio (CAR), is used to identify patients who have a high probability of postoperative complications; the diagnostic accuracy of the ratio is superior to CRP alone for the prediction of postoperative complications after colorectal surgery[10](#tca12990-bib-0010){ref-type="ref"} However, few studies have reported an association between CAR and AL after esophagectomy. In this study, we hypothesized that postoperative CAR could be a potential predictor for AL after esophagectomy.

In addition, the mainstream methods for predicting AL after esophagectomy are based on traditional statistical techniques (e.g. logistic regression, Cox proportional hazards regression) and some serological and biochemical indicators[4](#tca12990-bib-0004){ref-type="ref"}, [11](#tca12990-bib-0011){ref-type="ref"}, [12](#tca12990-bib-0012){ref-type="ref"}, [13](#tca12990-bib-0013){ref-type="ref"} However, shortcomings in traditional regression analysis exist. Particularly, in this study, CAR as a composite indicator has a multicollinearity relationship with CRP and albumin, which may lead to the wrong identification of relevant predictors in regression analysis[14](#tca12990-bib-0014){ref-type="ref"} Classification and regression tree (CART), as a data mining technique, is ideally suitable for the generation of clinical rules, which often enables the detection of complex interactions between predictors (including predictors with multicollinearity), which may be difficult or impossible to uncover using traditional statistical techniques[15](#tca12990-bib-0015){ref-type="ref"} CART has been shown to perform as well or better than other traditional statistical techniques, such as logistic regression analysis, and is increasingly being applied to diagnose disease and predict outcomes or complications in patients, including diabetes, trauma, and cancer.[16](#tca12990-bib-0016){ref-type="ref"}, [17](#tca12990-bib-0017){ref-type="ref"}, [18](#tca12990-bib-0018){ref-type="ref"}, [19](#tca12990-bib-0019){ref-type="ref"} To the best of our knowledge, CART analysis has not previously been used to assess the predictors of AL in patients after esophagectomy.

In the present study, we used CART analysis to construct a decision model for predicting the presence of AL in patients after esophagectomy using perioperative data (including CAR) and then evaluated the predictive performance of the decision model.

Methods {#tca12990-sec-0006}
=======

General information {#tca12990-sec-0007}
-------------------

The data of 461 patients who underwent esophagectomy and reconstruction of the esophageal tract in Jinling Hospital of Nanjing Medical University from January 2017 to April 2018 were retrospectively evaluated and enrolled. Patients were diagnosed by pathological examination of tumor tissue obtained during surgery. Of the 461 patients, we excluded four cases without sufficient clinicopathological data, five who suffered from distant metastasis, and two who died of early cancer recurrence. Of the remaining 450 cases, 353 men and 97 women were included (mean age 64.26 ± 8.4 years).

The perioperative data of the 450 patients were collected and summarized and included: gender, age, body mass index, history of prior chemotherapy and/or radiotherapy, diabetes, smoking history, drinking history, chest operation history, and location of tumor recorded from the postoperative histology findings. The biochemical parameters included preoperative: leukocyte, lymphocyte, neutrophil, erythrocyte, hemoglobin, thrombocyte, CRP, and albumin counts.

The surgery‐related data included were the duration of surgical produce (from skin incision to closure), American Society of Anesthesiologists (ASA) score, methods of anastomosis, and the type of surgery. The following surgical parameters were considered: tumor size, tumor histology, pathologic tumor stage, and tumor differentiation.

In all cases, white blood cells (WBCs), lymphocytes, neutrophils, red blood cells (RBCs), hemoglobin (Hb), thrombocyte, CRP, and albumin were measured on the third postoperative day (POD 3). None of the patients in our study were administered intravenous albumin supplementation. The postoperative CAR was calculated based on the results of laboratory tests. The calculation formula is as follows: CAR = (CRP on POD3)/(albumin on POD 3).

Definition of anastomotic leakage {#tca12990-sec-0008}
---------------------------------

AL was defined as follows: (i) the disruption of the anastomosis that leads to the outflow of the intraluminal content, which is sufficient to cause clinical symptoms[20](#tca12990-bib-0020){ref-type="ref"} and/or (ii) leaks confirmed by chest computed tomography, endoscopy, or surgical exploration.

Decision tree modeling and validation {#tca12990-sec-0009}
-------------------------------------

The 450 cases were split into two sets (training set with 356 patients; test set with 94 patients) according to the principle of simple random sampling. The training set was used to construct the decision tree model, which was then verified by the test set. All patients agreed to participate and signed informed consent. The Institutional Ethics Committee approved the study based on the principles of the Declaration of Helsinki.

Univariable analysis was performed to screen the candidate variables. CART was then performed on the training set to construct a decision tree model using these candidate variables. Beginning with a root node that contained all patients in the training set, all candidate variables were checked by recursive iterative algorithm to find the best variable to split the root node into two branches based on the Gini impurity index[21](#tca12990-bib-0021){ref-type="ref"} The tree branches were then divided into different child nodes that included a subgroup of patients. The process of node splitting was repeated for each predictor in the model and continued recursively until the cases were divided into two homogeneous groups: with and without AL.[22](#tca12990-bib-0022){ref-type="ref"} Pre pruning was carried out to avoid overfitting the CART model. The maximum tree depth was set to three layers; the minimum cases of parent and child node were both set to five. The optimal tree model was selected according to its predictive accuracy and clinical relevance.

The performance of the prediction model was validated by the test set. In order to evaluate the accuracy of the prediction model, we calculated the overall sensitivity, specificity, false positive and negative rates, positive and negative predictive values, and diagnostic accuracy of the model and established receiver operating characteristic (ROC) curves.

Statistical analysis {#tca12990-sec-0010}
--------------------

We used the χ^2^ or Fisher\'s exact test, as appropriate, for categorical variables. A Shapiro--Wilk test was used to assess whether the continuous data was normally distributed. On the basis of the results of the Shapiro--Wilk test, continuous variables were compared using Student\'s *t* or Mann--Whitney non‐parametric tests, as appropriate. Data were analyzed using SPSS version 21.0 (IBM Corp., Armonk, NY, USA). *P* values \< 0.05 were defined as statistically significant.

Results {#tca12990-sec-0011}
=======

Patient characteristics {#tca12990-sec-0012}
-----------------------

The prevalence of AL among 450 patients was 12.2% (55/450). Patients with AL in this study were diagnosed at median postoperative day 7 (range: 6--16). Characteristics of the training and validation datasets are presented in Table [1](#tca12990-tbl-0001){ref-type="table"}. There were no statistical differences between the two groups in any of the 35 variables studied (*P* \> 0.05), indicating that clinical characteristics in the two data sets were well distributed. Considering that leakages at cervical anastomosis and intrathoracic anastomosis may cause different degrees of infection, we performed independent sample T analysis to identify whether there was a statistical difference between the two methods. A total of 55 patients suffered from AL; there was no statistical difference between the CARs of the two anastomotic methods: (cervical anastomosis *n* = 45, CAR value: 5.67 ± 2.54; intrathoracic anastomosis *n* = 10, CAR value: 5.64 ± 2.59; *P* = 0.97). The non‐AL group consisted of 395 patients; the results of independent sample T analysis were: cervical anastomosis (*n* = 291) CAR value: 2.01 ± 1.84; intrathoracic anastomosis (*n* = 104) CAR value: 1.67 ± 1.34 (*P* = 0.09).

###### 

Characteristics of patients used in the data set

  --------------------------------------------------------------------------------------------------------------------
  No.                         Variable                                              Training\        Test\      *P*
                                                                                   (*n* = 356)     *(n* = 94)   
  --------------------------- --------------------------------------------------- -------------- -------------- ------
  1                           Gender                                                                            

  Male                        281                                                       72            0.90      

  Female                      75                                                        22                      

  2                           Age (years)                                          64.34 ± 8.41   64.12 ± 8.39  0.82

  3                           BMI (kg/m^2^)                                        23.01 ± 3.22   23.19 ± 3.16  0.57

  4                           History of prior chemotherapy and/or radiotherapy                                 

  Yes                         292                                                       83            0.16      

  No                          64                                                        11                      

  5                           Diabetes                                                                          

  Yes                         331                                                       88            0.83      

  No                          25                                                        6                       

  6                           Smoking history                                                                   

  Yes                         177                                                       47            0.96      

  No                          179                                                       47                      

  7                           Drinking history                                                                  

  Yes                         199                                                       59            0.23      

  No                          157                                                       35                      

  8                           Chest operation history                                                           

  Yes                         350                                                       93            0.80      

  No                          6                                                         1                       

  9                           Location of tumor                                                                 

  Upper                       35                                                        4             0.16      

  Middle                      215                                                       56                      

  Lower                       106                                                       34                      

  10                          Preoperative WBC (10^9^/L)                           5.81 ± 1.97    5.68 ± 1.70   0.53

  11                          Preoperative lymphocyte (10^9^/L)                    1.66 ± 0.56    1.65 ± 0.59   0.85

  12                          Preoperative neutrophil (10^9^/L)                    3.61 ± 1.80    3.51 ± 1.49   0.62

  13                          Preoperative RBC (10^12^/L)                          4.31 ± 0.56    4.42 ± 0.46   0.10

  14                          Preoperative Hb (g/L)                                131.6 ± 19.9   132.0 ± 15.5  0.25

  15                          Preoperative thrombocyte (10^9^/L)                   188.6 ± 60.8   204.3 ± 68.9  0.26

  16                          Preoperative CRP (mg/L)                               6.3 ± 22.6     4.14 ± 6.0   0.35

  17                          Preoperative albumin (g/L)                           41.17 ± 4.66   41.90 ± 4.19  0.16

  18                          ASA score                                                                         

  1                           288                                                       77            0.97      

  2                           57                                                        14                      

  3                           11                                                        3                       

  19                          Method of anastomosis                                                             

  Cervical anastomosis        267                                                       69            0.75      

  Intrathoracic anastomosis   89                                                        25                      

  20                          Type of surgery                                                                   

  Open operation              180                                                       49            0.08      

  VATS                        135                                                       27                      

  RATS                        41                                                        18                      

  21                          Tumor size (cm)                                                                   

  \< 3                        129                                                       31            0.77      

  3--5                        156                                                       45                      

  \> 5                        71                                                        18                      

  22                          Tumor histology                                                                   

  SCC                         326                                                       89            0.62      

  AC                          5                                                         1                       

  ASC                         2                                                         1                       

  Other                       23                                                        3                       

  23                          Pathologic tumor stage                                                            

  I                           140                                                       36            0.96      

  II                          75                                                        21                      

  III                         130                                                       35                      

  IV                          11                                                        2                       

  24                          Tumor differentiation                                                             

  High                        96                                                        22            0.72      

  Medium                      214                                                       61                      

  Low                         46                                                        11                      

  25                          Surgical duration (minutes)                          246.4 ± 65.8   244.9 ± 68.5  0.54

  26                          Postoperative WBC (10^9^/L)                          11.12 ± 3.36   11.30 ± 3.37  0.64

  27                          Postoperative lymphocyte count (10^9^/L)             0.74 ± 0.34    0.78 ± 0.36   0.15

  28                          Postoperative neutrophil count (10^9^/L)             9.72 ± 3.16    9.83 ± 3.20   0.76

  29                          Postoperative RBC (10^12^/L)                         3.84 ± 0.58    3.88 ± 0.47   0.13

  30                          Postoperative Hb (g/L)                               116.9 ± 19.3   118.9 ± 14.5  0.28

  31                          Postoperative thrombocyte (10^9^/L)                  173.8 ± 59.2   182.8 ± 57.8  0.19

  32                          Postoperative CRP (mg/L)                             77.7 ± 70.5    73.1 ± 51.4   0.48

  33                          Postoperative albumin (g/L)                          33.6 ± 3.93    33.9 ± 3.74   0.51

  34                          Postoperative CRP/albumin                            2.41 ± 2.31    2.23 ± 1.79   0.50

  35                          AL                                                                                

  Yes                         311                                                       84            0.59      

  No                          45                                                        10                      
  --------------------------------------------------------------------------------------------------------------------

AC, adenocarcinoma; ASC, adenosquamous carcinoma; AL, anastomotic leakage; ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell.

Classification and regression tree (CART) modeling in the training set {#tca12990-sec-0013}
----------------------------------------------------------------------

The results of univariate analysis in the training set revealed that ASA score, tumor size, pathologic tumor stage, surgical duration, postoperative lymphocyte count, postoperative CRP, preoperative RBC, postoperative albumin, and postoperative CAR were significantly different (*P* \< 0.05). The results are summarized in Table [2](#tca12990-tbl-0002){ref-type="table"}.

###### 

Univariate analysis of factors affecting AL after esophagectomy

  No.                         Variable                                             Non‐AL (*n* = 311)   AL (*n* = 45)     *P*
  --------------------------- --------------------------------------------------- -------------------- ---------------- -------
  1                           Gender                                                                                    
  Male                        241                                                          40                0.08       
  Female                      70                                                           5                            
  2                           Age (years)                                             64.26 ± 8.42       64.87 ± 8.42    0.65
  3                           BMI (kg/m^2^)                                           23.07 ± 3.31       22.62 ± 2.56    0.29
  4                           History of prior chemotherapy and/or radiotherapy                                         
  Yes                         256                                                          37                0.99       
  No                          55                                                           8                            
  5                           Diabetes                                                                                  
  Yes                         292                                                          39                0.08       
  No                          19                                                           6                            
  6                           Smoking history                                                                           
  Yes                         157                                                          20                0.45       
  No                          154                                                          25                           
  7                           Drinking history                                                                          
  Yes                         170                                                          29                0.22       
  No                          141                                                          16                           
  8                           Chest operation history                                                                   
  Yes                         305                                                          45                0.39       
  No                          6                                                            0                            
  9                           Location of tumor                                                                         
  Upper                       33                                                           2                            
  Middle                      181                                                          34                           
  Lower                       97                                                           9                 0.08       
  10                          Preoperative WBC (10^9^/L)                              5.80 ± 1.86        5.93 ± 2.60     0.66
  11                          Preoperative lymphocyte (10^9^/L)                       1.66 ± 0.57        1.67 ± 0.50     0.94
  12                          Preoperative neutrophil (10^9^/L)                       3.60 ± 1.68        3.75 ± 2.54     0.59
  13                          Preoperative RBC (10^12^/L)                             4.28 ± 0.55        4.52 ± 0.63     0.006
  14                          Preoperative Hb (g/L)                                   130.8 ± 20.1       136.6 ± 18.4    0.07
  15                          Preoperative thrombocyte (10^9^/L)                      187.5 ± 59.1       196.3 ± 71.5    0.36
  16                          Preoperative CRP (mg/L)                                 5.78 ± 15.42      10.28 ± 49.25    0.55
  17                          Preoperative albumin (g/L)                              41.1 ± 4.60        41.65 ± 5.02    0.47
  18                          ASA score                                                                                 
  1                           263                                                          25                0.00       
  2                           41                                                           16                           
  3                           7                                                            4                            
  19                          Method of anastomosis                                                                     
  Cervical anastomosis        245                                                          38                0.38       
  Intrathoracic anastomosis   66                                                           7                            
  20                          Type of surgery                                                                           
  Open operation              156                                                          24                0.55       
  Vats                        117                                                          18                           
  Rats                        38                                                           3                            
  21                          Tumor size (cm)                                                                           
  \< 3                        120                                                          9                 0.03       
  3--5                        132                                                          24                           
  \> 5                        59                                                           12                           
  22                          Tumor histology                                                                           
  SCC                         286                                                          40                0.81       
  AC                          4                                                            1                            
  ASC                         0                                                            2                            
  Other                       21                                                           2                            
  23                          Pathologic tumor stage                                                                    
  I                           121                                                          19                0.04       
  II                          72                                                           3                            
  III                         110                                                          20                           
  IV                          8                                                            3                            
  24                          Tumor differentiation                                                                     
  High                        84                                                           11                0.57       
  Medium                      185                                                          30                           
  Low                         42                                                           4                            
  25                          Surgical duration (minutes)                            240.5 ± 63.89      286.4 ± 65.79    0.00
  26                          Postoperative WBC (10^9^/L)                             11.19 ± 3.35       10.64 ± 3.42    0.31
  27                          Postoperative lymphocyte count (10^9^/L)                0.74 ± 0.34        0.64 ± 0.31     0.048
  28                          Postoperative neutrophil count (10^9^/L)                9.78 ± 3.18        9.35 ± 3.06     0.40
  29                          Postoperative RBC (10^12^/L)                            3.84 ± 0.58        3.83 ± 0.64     0.85
  30                          Postoperative Hb (g/L)                                  117.3 ± 19.7       114.8 ± 17.1    0.41
  31                          Postoperative thrombocyte (10^9^/L)                    174.23 ± 58.73     170.73 ± 63.18   0.71
  32                          Postoperative CRP (mg/L)                               64.24 ± 59.15      170.5 ± 72.99    0.00
  33                          Postoperative albumin (g/L)                             33.81 ± 3.85       31.9 ± 4.14     0.00
  34                          Postoperative CRP/albumin                               1.96 ± 1.87        5.52 ± 2.66     0.00

AC, adenocarcinoma; AL, anastomotic leakage; ASA score, American Society of Anesthesiologists (ASA) score; ASC, adenosquamous carcinoma; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell.

CART analysis was performed using the above nine candidate variables screened by univariate analysis. Postoperative CAR was the most important factor, with normalized importance of 100%. (Fig [1](#tca12990-fig-0001){ref-type="fig"}).

![Normalized importance of variables in predicting anastomotic leakage (AL) after esophagectomy in decision model tree. ASA, American Society of Anesthesiologists; CAR, C‐reactive protein to to albumin ratio; CRP, C‐reactive protein; CART, classification and regression tree; RBC, red blood cell; TNM, tumor node metastasis.](TCA-10-728-g001){#tca12990-fig-0001}

In order to avoid overfitting the predictive model, pre‐pruning was performed to ensure the optimal predictive accuracy of the decision tree.[23](#tca12990-bib-0023){ref-type="ref"} We removed some variables that were relatively less important (normalized importance \< 20%), such as preoperative RBC, tumor node metastasis, tumor size, and ASA score. As illustrated in Figure [2](#tca12990-fig-0002){ref-type="fig"}, the ultimate tree model consisted of three variables (postoperative CAR, surgical duration, postoperative lymphocyte count) with four terminal nodes.

![Decision tree model for the prediction of anastomotic leakage (AL) in the training set by classification and regression tree analysis. CAR, C‐reactive protein to to albumin ratio.](TCA-10-728-g002){#tca12990-fig-0002}

By traversing every possible value of each variable, the best split point could be identified by CART algorithm basing on the Gini impurity index[24](#tca12990-bib-0024){ref-type="ref"} the cutoff values of the three variables were chosen by the CART algorithm. The postoperative CAR was considered the initial splitting variable, with a cutoff value of 4.25. Among patients with a postoperative CAR ≤ 4.25, surgical duration was considered as the second splitting variable, with a cutoff value of 405 minutes. A low‐risk group was composed of node 3 (postoperative CAR ≤ 4.25, surgical duration ≤ 405 minutes), with a possibility of AL of 3.5% (10/289). A high‐risk group was composed of node 4 (postoperative CAR ≤ 4.25, surgical duration \> 405 minutes), with a possibility of AL of 75% (3/4). Among patients with a postoperative CAR \> 4.25, the cutoff values were 0.39 for postoperative lymphocytes. A relatively high‐risk group consisted of node 6 (postoperative CAR \> 4.25, postoperative lymphocyte \> 0.39), with a possibility of AL of 41.5% (22/53). A high‐risk group was made up of node 5 (postoperative CRP/albumin \> 4.25, postoperative lymphocyte ≤ 0.39), with a possibility of AL of 100% (10/10).

Using all of the variables in the model, we constructed ROC curves to access the accuracy of the CART model. The area under the ROC curve was 0.92 (Fig [3](#tca12990-fig-0003){ref-type="fig"}).

![Receiver operating characteristic (ROC) curve for the classification and regression tree model in the training set.](TCA-10-728-g003){#tca12990-fig-0003}

Validation of CART analysis in the test set {#tca12990-sec-0014}
-------------------------------------------

To evaluate the predictive accuracy of the model, the established CART model was verified in the test set (*n* = 94). According to the results, the overall sensitivity, specificity, false positive and negative rates, positive and negative predictive values, and diagnostic accuracy of the tree model for AL were 80%, 98.8%, 1.2%, 20%, 88.9%, 97.6%, and 96.8%, respectively (Table [3](#tca12990-tbl-0003){ref-type="table"}). An ROC curve for the CART model in the test set was built, the area of which was 0.95 (Fig [4](#tca12990-fig-0004){ref-type="fig"}).

###### 

Performance of the predictive model for AL verified in the test set

                Observed                    
  ----------- ------------- --------------- ---------------------
  Predicted        Yes            No        
  Yes               8              1           PPV 88.9% (8/9)
  No                2             83          NPV 97.6% (83/85)
               Sensitivity    Specificity    Diagnostic accuracy
               80% (8/10)    98.8% (83/84)          96.8%

AL, anastomotic leakage; NPV negative predictive value; PPV positive predictive value.

![Receiver operating characteristic (ROC) curve for the classification and regression tree model in the test set.](TCA-10-728-g004){#tca12990-fig-0004}

Discussion {#tca12990-sec-0015}
==========

AL is defined as an esophagogastrostomy anastomotic dehiscence diagnosed during the postoperative period. If it cannot be diagnosed in time, it may result in disastrous consequences, such as septic shock, mediastinitis, acute respiratory distress syndrome, and death.[25](#tca12990-bib-0025){ref-type="ref"} A diagnosis of AL is usually made on the seventh postoperative day, after the onset of clinical symptoms[1](#tca12990-bib-0001){ref-type="ref"}, [26](#tca12990-bib-0026){ref-type="ref"} Therefore, precise prediction of patients at high risk of AL prior to the incidence of symptoms may decrease morbidity and mortality. In this study, a decision model for predicting the presence of AL in patients after esophagectomy was constructed from a training dataset using the CART algorithm. The accuracy of the prediction model was then validated with a test dataset. According to results verified by the test set, the decision model had good performance and may help clinicians to diagnose and administer treatment in a timely manner.

Recently, decision tree algorithms have been found to accomplish the same goals but with fewer assumptions or greater accuracy than other traditional statistical techniques, such as logistic regression analysis[27](#tca12990-bib-0027){ref-type="ref"} As a technique that is ideally suited to the generation of clinical decision rules, CART analysis has a number of advantages compared to other traditional statistical methods[28](#tca12990-bib-0028){ref-type="ref"}, [29](#tca12990-bib-0029){ref-type="ref"} There have been examples of CART tree algorithms being used to create clinical decision rules with proven effectiveness. For instance, one study used CART analysis to develop a decision model that may help clinicians to make an early diagnosis of severe acute pancreatitis[30](#tca12990-bib-0030){ref-type="ref"} Another study established a decision tree model for the prediction of congestive heart failure; the sensitivity and specificity of the prediction model were 97.2% and 97.7%, respectively[31](#tca12990-bib-0031){ref-type="ref"} Yang Fei *et al*. designed CART and logistic regression models for the prediction of portosplenomesenteric vein thrombosis and found that the CART model demonstrated better overall properties than the logistic regression model[11](#tca12990-bib-0011){ref-type="ref"} However, CART analysis has not been used to predict the occurrence of AL after esophagectomy.

In the present study, we presupposed that the novel indicator CAR might be a potential predictor for AL in patients after esophagectomy. CAR is a composite indicator composed of CRP and albumin, which means that if the three indicators (CAR, CRP, and albumin) were applied to multiple regression analysis, the collinearity between them will affect the accuracy of the regression equation and contribute to unreliable results[14](#tca12990-bib-0014){ref-type="ref"} However, CART analysis is not hindered by multicollinearity; collinearity is often used to an advantage in tree algorithms[32](#tca12990-bib-0032){ref-type="ref"} As illustrated in Figure [1](#tca12990-fig-0001){ref-type="fig"}, we successfully integrated the three indicators into the prediction model using CART analysis and obtained their normalized importance for AL, which were 100%, 79.2%, and 21.8%, respectively.

According to the results verified in the test set, the area under ROC curve revealed that the CART model had good predictive accuracy (sensitivity 80%, specificity 98.8%, diagnostic accuracy 96.8%, area under ROC curve 0.95). CAR was identified as the most important indicator of AL in this trial. The novel index CAR, as a sensitive marker of systemic inflammatory response, is a potential predictive indicator for clinical outcomes. For example, one study showed that CAR at admission can be used as an independent predictor of 180‐day mortality in patients with severe sepsis or septic shock and proved the predictive value of the indicator[33](#tca12990-bib-0033){ref-type="ref"} Gibson *et al*. found that elevated CAR is an early predictor of steroid‐refractory acute severe ulcerative colitis.[34](#tca12990-bib-0034){ref-type="ref"} In our study, we clarified the association between CAR and AL; patients with elevated CAR on POD 3 had a higher tendency to develop AL, approximately four days prior to the median time to AL diagnosis. This indicates that clinicians could monitor these indicators to determine patients at high risk of AL, prior to the appearance of clinical symptoms. To exclude AL in high‐risk patients we could conduct close clinical assessment and radiological examination in our center; however, we prefer to continue with the administration of enteral nutrition to low‐risk patients. This measure may bring significant benefits to patients because postoperative enteral nutrition has been proven to reduce the incidence of life‐threatening surgical complications and improve the completion rate of clinical pathways for thoracic esophagectomy[35](#tca12990-bib-0035){ref-type="ref"}

In conclusion, the decision tree model (consisting of surgical duration, postoperative lymphocyte count, and postoperative CAR) showed good performance for predicting AL after esophagectomy using the CART algorithm; the CAR was proven the key indicator to the model. The CART model may help clinicians to identify patients at high risk of developing AL and to administer timely treatment.
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